Figure 1.
Expected E2 levels during the menstrual cycle and under gonadotropin-releasing hormone (GnRH) antagonist therapy with and without add-back therapy (ABT).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.